Chronic treatment with amyloid beta(1-42) inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
16256077
DOI
10.1016/j.brainres.2005.09.021
PII: S0006-8993(05)01329-6
Knihovny.cz E-zdroje
- MeSH
- amyloidní beta-protein aplikace a dávkování fyziologie MeSH
- buněčná diferenciace fyziologie MeSH
- buněčné linie MeSH
- cholinergní látky farmakologie MeSH
- hemicholinium 3 farmakologie MeSH
- krysa rodu Rattus MeSH
- membránové transportní proteiny účinky léků genetika metabolismus MeSH
- messenger RNA analýza MeSH
- myši MeSH
- neurony účinky léků enzymologie metabolismus MeSH
- peptidové fragmenty aplikace a dávkování fyziologie MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- proteinkinasa C metabolismus MeSH
- signální transdukce fyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- amyloid beta-protein (1-42) MeSH Prohlížeč
- amyloidní beta-protein MeSH
- choline transporter MeSH Prohlížeč
- cholinergní látky MeSH
- hemicholinium 3 MeSH
- membránové transportní proteiny MeSH
- messenger RNA MeSH
- peptidové fragmenty MeSH
- proteinkinasa C MeSH
We investigated the influence of the amyloid-beta-peptide(1-42) on hemicholinum-3-sensitive high-affinity choline uptake in NG108-15 cells. RT-PCR analysis revealed the presence of mRNA for a choline transporter-like protein but not for cholinergic high-affinity choline transporter. Differentiation of cells increased both hemicholinum-3-sensitive choline uptake and high-affinity hemicholinium-3 binding. This transport was not influenced by tenfold excess of carnitine. Continuous presence of submicromolar concentrations of amyloid-beta-peptide(1-42) during differentiation resulted in a decrease of both choline uptake and hemicholinium-3 binding. These effects were not present when amyloid-beta-peptide(1-42) was added 5 min prior to measurements. Neither differentiation nor amyloid-beta-peptide(1-42) treatment changed levels of choline transporter-like protein mRNA. Protein kinase C inhibition by staurosporine or its inactivation by continuous presence of tetradecanoyl phorbol acetate prevented the inhibitory effect of amyloid-beta-peptide(1-42) treatment on choline uptake. Activation of protein kinase C by tetradecanoyl phorbol acetate during measurement had inhibitory effect on choline uptake in control but not amyloid-beta-peptide(1-42)-treated cells. The concentration of amyloid-beta-peptide(1-42) maximally effective on hemicholinium-3-sensitive choline uptake had no effect on cell growth, oxidative activity, membrane integrity, number of surface muscarinic receptors, caspase-3 and -8 activities, or uptake of deoxyglucose. Results demonstrate that long-term treatment with non-toxic concentrations of amyloid-beta-peptide(1-42) downregulates choline uptake presumably mediated by a choline transporter-like protein through activation of protein kinase C signaling. The decrease of choline uptake may have relevance to the pathogenesis of Alzheimer's disease.
Citace poskytuje Crossref.org